Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation

Journal of Investigative Dermatology

Volumn 110, Issue 3, 1998, Pages 215-217

  Böni, Roland ^a   Matt, David ^a   Voetmeyer, Alexander ^b   Burg, Günter ^a   Zhuang, Zhengping ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chromosome 1p; Chromosome 9q; Loss of heterozygosity; Melanoma

Indexed keywords

KI 67 ANTIGEN;

ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME 1P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0031894942     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00109.x     Document Type: Article

References (15)

1. Balaban GB, Herlyn M, Clark WH Jr, Nowell PC: Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet 19:113-122, 1986
2. Bale SJ, Dracopoli NC, Tucker MA, et al: Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p [published erratum appears in N Engl J Med 324 (13):925, 1991]. N Engl J Med 320:1367-1372, 1989
3. Böni R, Doguoglu A, Burg G, Müller B, Dununer R: MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol 35:416-418, 1996
4. Bridge J, Leong SP, Burgess AC, Thompson F, Trent JM: Examination of clonal variants from human malignant melanoma studied by chromosome banding analysis. Melanoma Res 1:289-296, 1991
5. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219 229, 1984
6. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990.
7. Goldstein AM, Dracopoli NC, Engelstem M, Fraser MC, Clark WH Jr, Tucker MA: Linkage of cutaneous malignant melanoma dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am J Hum Genet 54:489-496, 1994
8. Gordon LG, Lowry WS, Pedlow PJ, Patterson CC: Poor prognosis for malignant melanoma in Northern Ireland: a multivariate analysis. Br J Cancer 63:283-6, 1991
9. Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H, Rees JL: Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res 56:589-593, 1996.
10. Kacker RK, Giovanella BC, Pathak S: Consistent karyotypic abnormalities in human malignant melanomas. Anticancer Res 10:859-871, 1990
11. Limon J, Dal Cin P, Sait SN, Karakousis C, Sandberg AA: Chromosome changes in metastatic human melanoma. Cancer Genet Cytogenet 30:201-211, 1988.
12. Ozisik YY, Meloni AM, Altungoz O, Peier A, Karakousis C, Leong SP, Sandberg AA: Cytogenetic findings in 21 malignant melanomas. Cancer Genet Cytogenet 77:69-73, 1994
13. Pedersen MI, Wang N: Chromosomal evolution in the progression and metastasis of human malignant melanoma. A multiple lesion study. Cancer Genet Cytogenet 41:185-201, 1989
14. Ramsay JA, From L, Iscoe NA: MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanoma. J Invest Dermatol 105:22-26, 1995
15. Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, Lubensky IA: A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. Am J Pathol 146:620-625, 1995